Prosight Management, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Prosight Management, LP disclosed 41 US equity positions worth $394.4m in its Q3 2024 13F filing. The largest position was ADCT at 7.7% of the reported book, followed by LKFT and BBIO.
What did Prosight Management, LP own in Q3 2024? Top 41 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ADCT ADC THERAPEUTICS SA | Healthcare | 7.7% | $30.4m | 9,636,237 | – | |
| 2 | LKFT GALAPAGOS NV | Healthcare | 7.5% | $29.6m | 1,028,843 | – | |
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 7.0% | $27.7m | 1,086,810 | – | |
| 4 | ABCL ABCELLERA BIOLOGICS INC | Healthcare | 6.0% | $23.6m | 9,079,539 | – | |
| 5 | MGTX MEIRAGTX HLDGS PLC | 5.2% | $20.4m | 4,900,570 | – | ||
| 6 | ROIV ROIVANT SCIENCES LTD | Healthcare | 5.0% | $19.9m | 1,721,512 | – | |
| 7 | STTK SHATTUCK LABS INC | Healthcare | 5.0% | $19.8m | 5,678,726 | – | |
| 8 | MIRM MIRUM PHARMACEUTICALS INC | Healthcare | 4.6% | $18.2m | 465,825 | – | |
| 9 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 4.5% | $17.9m | 165,602 | – | |
| 10 | MCK MCKESSON CORP | Healthcare | 4.5% | $17.7m | 35,822 | – | |
| 11 | KURA KURA ONCOLOGY INC | Healthcare | 3.5% | $13.8m | 705,109 | – | |
| 12 | SDGR SCHRODINGER INC | Healthcare | 3.3% | $13.0m | 700,000 | – | |
| 13 | ZYME ZYMEWORKS INC | Healthcare | 2.9% | $11.5m | 917,599 | – | |
| 14 | ACCDUSD ACCOLADE INC | 2.7% | $10.8m | 2,801,598 | – | ||
| 15 | DXCM DEXCOM INC | Healthcare | 2.7% | $10.7m | 160,000 | – | |
| 16 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.7% | $10.7m | 554,103 | – | |
| 17 | IMVT IMMUNOVANT INC | Healthcare | 2.7% | $10.5m | 370,000 | – | |
| 18 | CYTK CYTOKINETICS INC | Healthcare | 2.6% | $10.2m | 192,700 | – | |
| 19 | JANX JANUX THERAPEUTICS INC | Healthcare | 2.4% | $9.3m | 205,000 | – | |
| 20 | PROTHENA CORP PLC | 2.1% | $8.1m | 483,467 | – | ||
| 21 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.8% | $7.1m | 62,000 | – | |
| 22 | ERAS ERASCA INC | Healthcare | 1.4% | $5.4m | 1,984,010 | – | |
| 23 | HAE HAEMONETICS CORP MASS | Healthcare | 1.3% | $5.2m | 65,000 | – | |
| 24 | LIVN LIVANOVA PLC | Healthcare | 1.2% | $4.7m | 90,000 | – | |
| 25 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.1% | $4.4m | 410,830 | – | |
| 26 | 2655787D BLUEPRINT MEDICINES CORP | 1.1% | $4.4m | 47,100 | – | ||
| 27 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 1.1% | $4.2m | 137,614 | – | |
| 28 | CTMX CYTOMX THERAPEUTICS INC | Healthcare | 0.9% | $3.6m | 3,022,109 | – | |
| 29 | SGHT SIGHT SCIENCES INC | 0.8% | $3.3m | 531,222 | – | ||
| 30 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.8% | $3.0m | 48,000 | – | |
| 31 | RCKT ROCKET PHARMACEUTICALS INC | Healthcare | 0.7% | $2.9m | 159,369 | – | |
| 32 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 0.7% | $2.7m | 130,000 | – | |
| 33 | MURAL ONCOLOGY PUB LTD CO | 0.5% | $1.8m | 570,620 | – | ||
| 34 | MRVI MARAVAI LIFESCIENCES HLDGS I | Healthcare | 0.4% | $1.7m | 208,200 | – | |
| 35 | VINCERX PHARMA INC | 0.4% | $1.6m | 2,206,505 | – | ||
| 36 | RNTX AILERON THERAPEUTICS INC | 0.3% | $1.3m | 372,157 | – | ||
| 37 | SELECT MED HLDGS CORP | 0.2% | $908.9k | 26,065 | – | ||
| 38 | OVID OVID THERAPEUTICS INC | Healthcare | 0.2% | $860.5k | 729,208 | – | |
| 39 | IMNM IMMUNOME INC | Healthcare | 0.1% | $572.2k | 39,135 | – | |
| 40 | IMRX IMMUNEERING CORP | 0.1% | $473.1k | 190,000 | – | ||
| 41 | ACHC ACADIA HEALTHCARE COMPANY IN | Healthcare | 0.1% | $359.3k | 5,666 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.